Zymedyne Therapeutics

0 followers


Zymedyne aims to develop safer, more effective treatments for chronic, neuropathic pain by targeting human Cav3.2 “T-type” calcium channels that are known to be crucial in pain signalling. Unlike opioids, our technology aims to achieve pain relief without the detrimental side effects of weight gain,... Read more

Industries

Stage

Employees

Links

Org chart

Chris Bladen
Acting Chief Executive Officer

Chris Bladen

Collapse
No reports!